medigraphic.com
ISSN 1817-5996 (Digital)

2016, Número 2

<< Anterior Siguiente >>

Rev Cub de Reu 2016; 18 (2)


Hemorragia Alveolar Difusa como forma de presentación de lupus eritematoso sistémico asociado a tiroiditis autoinmune

Charaja CKS, Ayala LEN, García RMJ, Cornejo OMP, Yupari CME, Saldarriaga RLM

Idioma: Español
Referencias bibliográficas: 20
Paginas: 155-159
Archivo PDF: 340.05 Kb.


RESUMEN

El lupus eritematoso sistémico (LES) es una enfermedad inflamatoria crónica de naturaleza autoinmune, de etiología desconocida en la que hay daño celular y tisular por autoanticuerpos y que cursa con un amplio espectro de manifestaciones clínicas. La hemorragia alveolar difusa es una forma de presentación poco frecuente en pacientes con LES, raramente debuta como una manifestación inicial de la enfermedad. Aproximadamente 2% de todos los pacientes con LES presentan este cuadro, siendo su asociación con otras enfermedades de origen inmune, entre ellas la tiroiditis autoinmune un caso excepcional con elevada mortalidad.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ong SG, Choy CH. Autoimmune thyroid disease in a cohort of Malaysian SLE patients: frequency, clinical and immunological associations. Lupus 2015; 0: 1–8.

  2. Alves C, Vicente T, Fragomeni M. Diagnosis of juvenile systemic lupus erythematosus in adolescents with hashimoto thyroiditis:Two case reports. Acta reumatol Port. 2010;35(3):362-65

  3. Watad A, Cohen AD, Comaneshter D, Tekes-Manova D, Amital H. Hyperthyroidism association with SLE, lessons from real-life data. A case–control study. Autoimmunity. 2015; 14:1-4.

  4. Hamza RT, Awwad KS, Temsah KA, Hamed AI. Polymorphism of protein tyrosine phosphatase PTPN22 in Egyptian children and adolescents with systemic lupus erythematosus: relation to thyroid autoimmunity. Int J Adolesc Med Health. 2013; 25(2):143-149.

  5. Mader R, Mishail S, Adawi M, Lavi I, Luboshitzky. R. Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Clin Rheumatol. 2007; 26(11):1891-4.

  6. Kumar K, Kumar A, Sarathi Karmakar P, Ghosh A. The spectrum of thyroid disorders in systemic lupus erythematosus. Rheumatol Int. 2012; 32:73–78

  7. Martínez-Martínez M, Abud-Mendoza C. Hemorragia alveolar difusa en pacientes con lupus eritematoso sistémico. Manifestaciones clínicas, tratamiento y pronóstico. Reumatol Clin. 2014;10:248–253.

  8. Khor CG, Kan SL, Tan BE. Pulmonary manifestation as initial presentation for systemic lupus erythematosus. Int J Rheum Dis. 2014 Feb 3. doi: 10.1111/1756-185X.12302

  9. Lara A, Schwarz M. Diffuse Alveolar Hemorrhage. Chest. 2010;137:1164–1171.

  10. Kamen D, Strange C. Pulmonary manifestations of systemic lupus erythematosus, Clin Chest Med, 2010; 31(3):479–488.

  11. Shen M, Zeng X, Tian X, Zhang F, Zeng X, Zhang X, Xu W. Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China. Lupus 2010; 19(11): 1326-30.

  12. Martínez-Martínez, Abud-Mendoza C. Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus. 2011; 20:56 8–74.

  13. Rojas-Serrano J, Pedroza J, Regalado J, Robledo J, Reyes E, Sifuentes-Osornio J, et al. High prevalence of infections in patients with systemic lupus erythematosus and pulmonary haemorrhage. Lupus 2008; 17(4): 295-9.

  14. Kasturi S, Sammaritano LR. Corticosteroids in Lupus. Rheum Dis Clin North Am. 2016;42(1):47-62

  15. Parker BJ, Bruce IN. High dose methylprednisolone therapy for the treatment of severe systemic lupus erythematosus. Lupus 2007; 16(6):387-393.

  16. Krause M, Cartin-Ceba R, Specks U, Peikert T. Update on Diffuse Alveolar Hemorrhage and Pulmonary Vasculitis. Immunol Allergy Clin North Am. 2012; 32(4):587–600.

  17. Andrade C, Mendonça T, Farinha F, Correia J, Marinho A, Almeida I, et al. Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus. 2016; 25(1):75-80.

  18. Rekha Hans, Ratti Sharma, Neelam Marwaha. Dramatic response to plasma exchange in systemic lupus erythematosus with acute complications: Report of two cases. Indian J Crit Care Med. 2013;17(6):385-7

  19. Pons-Estel GJ, Salerni GE, Serrano RM, Gomez-Puerta JA, Plasin MA, Aldasoro E, et al. Therapeutic plasma exchange for the management of refractory systemic. Autoimmun Rev. 2011;10(11):679-84

  20. Braun-Moscovici Y, Butbul-Aviel Y, Guralnik L, Toledano K, Markovits D, Rozin A, et al. A Rituximab: rescue therapy in life- threatening complications or refractory autoimmune diseases: a single center experience. Rheumatol Int. 2013; 33:1495- 1504.




2020     |     www.medigraphic.com